Angeles Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$528K Buy
6,043
+553
+10% +$53K 0.03% 220
2025
Q4
$531K Buy
5,490
+1,455
+36% +$141K 0.03% 199
2025
Q3
$384K Buy
4,035
+65
+2% +$5.97K 0.02% 220
2025
Q2
$346K Buy
3,970
+661
+20% +$56.1K 0.02% 233
2025
Q1
$297K Buy
3,309
+224
+7% +$20K 0.02% 212
2024
Q4
$246K Buy
3,085
+822
+36% +$71.2K 0.02% 253
2024
Q3
$204K Buy
+2,263
New +$190K 0.02% 258
2023
Q4
Sell
-2,888
Closed -$226K 267
2023
Q3
$226K Buy
2,888
+577
+25% +$48.3K 0.03% 152
2023
Q2
$204K Buy
+2,311
New +$199K 0.03% 176
2022
Q4
Sell
-2,611
Closed -$211K 220
2022
Q3
$211K Buy
+2,611
New +$235K 0.04% 156

Other funds holding MDT

Angeles Wealth Management's MDT Position: Q1 2026 in Review

Angeles Wealth Management increased its Medtronic (MDT) stake by 10% in Q1 2026, buying an estimated $53K and bringing the position to 6,043 shares worth $528K. The position accounts for 0.03% of the portfolio, ranked #220.

Angeles Wealth Management first reported a position in MDT in Q3 2022 and has held it in 10 quarters since. The position peaked at $531K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Angeles Wealth Management held 6,043 shares of Medtronic worth $528K as of Q1 2026.
  • Angeles Wealth Management bought 553 Medtronic shares in Q1 2026, an estimated $53K.
  • Medtronic made up 0.03% of Angeles Wealth Management's portfolio in Q1 2026, its #220 holding.
  • Angeles Wealth Management first reported a position in Medtronic in Q3 2022 and has held it in 10 quarters since.
  • Angeles Wealth Management's Medtronic position peaked at $531K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.